Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

Recent breakthroughs in targeted therapy and immunotherapy have revolutionized the treatment of lung cancer, the leading cause of cancer-related deaths in the United States and worldwide. Here we provide an overview of recent progress in immune checkpoint blockade therapy for treatment of non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Xingxiang, Wu, Lin, Su, Dan, Mao, Weimin, Fang, Bingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225701/
https://www.ncbi.nlm.nih.gov/pubmed/30409126
http://dx.doi.org/10.1186/s12885-018-4990-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225701/
https://www.ncbi.nlm.nih.gov/pubmed/30409126
http://dx.doi.org/10.1186/s12885-018-4990-5

Ejemplares similares